SRSF5: A Protein Regulating Splicing and Gene Expression (G6430)

Target Name: SRSF5

NCBI ID: G6430

SRSF5

SRSF5: A Protein Regulating Splicing and Gene Expression

Splicing factor, arginine/serine-rich 5 (SRSF5) is a protein that plays a crucial role in the regulation of gene expression in the nucleus. It is a key regulator of splicing, which is the process by which the cell removes non-coding regions from the RNA molecule and replaces them with coding sequences. SRSF5 is a member of the SRSF family of proteins, which are known for their ability to recruit splicing factors to specific exons during splicing.

SRSF5 is a 21-kDa protein that is expressed in most tissues of the body. It is highly conserved, with only a single amino acid difference between the mouse and human versions. SRSF5 is predominantly localized to the nuclei of various cell types, including neurons, muscle cells, and epithelial cells. It is also expressed in the placenta, which is a vital organ that supports the development and maintenance of the fetus.

SRSF5 is involved in the regulation of gene expression by splicing. During splicing, SRSF5 recruits splicing factors to specific exons, which are then responsible for removing non-coding regions from the RNA molecule and replacing them with coding sequences. SRSF5 is essential for the accurate regulation of gene expression, as errors in splicing can lead to the production of either correctly or incorrectly encoded proteins.

SRSF5 has been shown to play a role in a variety of biological processes, including cell growth, differentiation, and development. For example, SRSF5 has been shown to be involved in the regulation of neuronal excitability and synaptic plasticity. It has also been shown to play a role in the regulation of muscle contractions and the development of cancer.

SRSF5 is a potential drug target, as it has been shown to be involved in a variety of cellular processes that are often disrupted in diseases such as cancer, neurodegenerative diseases, and developmental disorders. For example, SRSF5 has been shown to be involved in the regulation of the transition from quiescence to active cell growth, which is a critical process for the development and maintenance of tissues. It is also involved in the regulation of cell death, which is a critical process for maintaining tissue homeostasis and promoting repair and regeneration.

In addition to its potential clinical applications, SRSF5 is also a valuable research tool for the study of splicing and gene regulation. The SRSF5 gene has been cloned and sequenced, and numerous studies have characterized its expression and function in various cell types. These studies have provided valuable insights into the regulation of splicing and gene expression, and have helped to further our understanding of the complex processes that underlie cellular behavior.

Overall, SRSF5 is a protein that plays a crucial role in the regulation of splicing and gene expression. Its role in these processes makes it an attractive target for the development of new drugs and therapies for a variety of diseases. Further research is needed to fully understand the mechanisms of SRSF5's function and its potential as a drug target.

Protein Name: Serine And Arginine Rich Splicing Factor 5

Functions: Plays a role in constitutive splicing and can modulate the selection of alternative splice sites

The "SRSF5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SRSF5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets